Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping-Reference-Cited by-同舟云学术

Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping

Published:2019-04 Issue:4 Volume:57 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Kwon Yong Jun¹,Shin Jong Hee¹,Byun Seung A¹,Choi Min Ji¹,Won Eun Jeong¹,Lee Dain¹,Lee Seung Yeob¹,Chun Sejong¹,Lee Jun Hyung¹,Choi Hyun Jung¹,Kee Seung Jung¹,Kim Soo Hyun¹,Shin Myung Geun¹

Affiliation:

1. Department of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju, Republic of Korea

Abstract

Candida auris is an emerging worldwide fungal pathogen. Over the past 20 years, 61 patient isolates of C. auris (4 blood and 57 ear) have been obtained from 13 hospitals in Korea.

Funder

National Research Foundation of Korea

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01624-18

Reference26 articles.

1. First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris

2. Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

3. Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment